Literature DB >> 19327582

Diagnosis and management of acquired pure red cell aplasia.

Kenichi Sawada1, Makoto Hirokawa, Naohito Fujishima.   

Abstract

Pure red cell aplasia is a syndrome characterized by a severe normocytic anemia, reticulocytopenia, and absence of erythroblasts from an otherwise normal bone marrow. Although the causes and natural course of this syndrome are variable and although the anemia in some patients can be managed by treatment of an underlying inflammatory or neoplastic disease, the pathogenesis of a large number of cases is autoimmune, including those associated with thymoma, and are best managed with immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19327582     DOI: 10.1016/j.hoc.2009.01.009

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  15 in total

1.  Guest editorial: the seven wonders of erythropoiesis.

Authors:  Kenichi Sawada
Journal:  Int J Hematol       Date:  2011-01-12       Impact factor: 2.490

Review 2.  [Normal bone marrow and common reactive alterations].

Authors:  A Tzankov; S Dirnhofer; C Beham-Schmid
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

Review 3.  Paraneoplastic syndromes: an approach to diagnosis and treatment.

Authors:  Lorraine C Pelosof; David E Gerber
Journal:  Mayo Clin Proc       Date:  2010-09       Impact factor: 7.616

4.  Pure red cell aplasia caused by ribavirin and interferon treatment.

Authors:  Andrew J Skabelund; Timothy R Hauser; Kevin J Goist
Journal:  Clin J Gastroenterol       Date:  2011-07-30

5.  A novel mutation and unusual clinical features in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome.

Authors:  Keun Wook Bae; Bo Eun Kim; Jin-Ho Choi; Joo Hoon Lee; Young Seo Park; Gu-Hwan Kim; Han Wook Yoo; Jong Jin Seo
Journal:  Eur J Pediatr       Date:  2011-10-07       Impact factor: 3.183

6.  Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation.

Authors:  F Khan; M A Linden; N D Zantek; G M Vercellotti
Journal:  Transfus Med       Date:  2014-05-09       Impact factor: 2.019

7.  TSPAN33 is a novel marker of activated and malignant B cells.

Authors:  Van Phi Luu; Peter Hevezi; Felipe Vences-Catalan; José Luis Maravillas-Montero; Clayton Alexander White; Paolo Casali; Luis Llorente; Juan Jakez-Ocampo; Guadalupe Lima; Natalia Vilches-Cisneros; Juan Pablo Flores-Gutiérrez; Leopoldo Santos-Argumedo; Albert Zlotnik
Journal:  Clin Immunol       Date:  2013-08-15       Impact factor: 3.969

8.  Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Sung-Hoon Jung; Jae-Sook Ahn; Deok-Hwan Yang; Hyung Chul Park; Soo-Young Bae; Yeo-Kyeoung Kim; Hyeoung-Joon Kim; Je-Jung Lee
Journal:  Case Rep Oncol       Date:  2012-02-29

9.  Pure red cell aplasia caused by acute hepatitis a.

Authors:  Tae Heon Lee; Suk Joong Oh; Soojung Hong; Kyu Bek Lee; Hyosoon Park; Hee-Yeon Woo
Journal:  Chonnam Med J       Date:  2011-04-26

Review 10.  Missing Cells: Pathophysiology, Diagnosis, and Management of (Pan)Cytopenia in Childhood.

Authors:  Miriam Erlacher; Brigitte Strahm
Journal:  Front Pediatr       Date:  2015-07-13       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.